e-z cinnamic acid has been researched along with 2,4-thiazolidinedione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, W; Gross, C; Miller, WL; Neogi, P | 1 |
1 other study(ies) available for e-z cinnamic acid and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity.
Topics: 17-Hydroxysteroid Dehydrogenases; 3T3 Cells; Animals; Cells, Cultured; Cinnamates; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucose; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred Strains; PPAR gamma; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Thiazolidinediones; Transcriptional Activation | 2004 |